Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF OPERATIONS

v3.22.2.2
CONDENSED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Total revenues $ 22,410 $ 21,543 $ 68,964 $ 128,827
Costs and expenses:        
Cost of product sales 250 151 1,407 596
Research and development 14,666 18,300 44,907 51,933
Selling, general and administrative 25,897 22,877 80,279 67,376
Total costs and expenses 40,813 41,328 126,593 119,905
Income (loss) from operations (18,403) (19,785) (57,629) 8,922
Interest income 192 14 255 31
Interest expense (826) (1,317) (2,600) (3,561)
Income (loss) before income taxes (19,037) (21,088) (59,974) 5,392
Provision for (benefit from) income taxes 0 (136) 0 665
Net income (loss) $ (19,037) $ (20,952) $ (59,974) $ 4,727
Net income (loss) per share, basic and diluted        
Basic (in dollars per share) $ (0.11) $ (0.12) $ (0.35) $ 0.03
Diluted (in dollars per share) $ (0.11) $ (0.12) $ (0.35) $ 0.03
Weighted average shares used in computing net income (loss) per share, basic and diluted        
Basic (in shares) 172,836 170,886 172,256 170,297
Diluted (in shares) 172,836 170,886 172,256 176,452
Product sales, net        
Total revenues $ 19,188 $ 16,012 $ 53,935 $ 45,441
Revenues from collaborations        
Total revenues 722 4,531 12,529 73,886
Government contract        
Total revenues $ 2,500 $ 1,000 $ 2,500 $ 9,500